Skip to main content
logo
Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.2876
+0.0038 (1.34%)
At close: Aug 7, 2026, 4:00 PM EDT
0.2867
-0.0009 (-0.31%)
Pre-market: Aug 10, 2026, 8:15 AM EDT

Vistagen Therapeutics Revenue

In the fiscal year ending March 31, 2026, Vistagen Therapeutics had annual revenue of $1.27M with 161.11% growth. Vistagen Therapeutics had revenue of $465.00K in the quarter ending March 31, 2026.

Revenue (ttm)
$1.27M
Revenue Growth
+161.11%
P/S Ratio
9.30
Revenue / Employee
$30,951
Employees
41
Market Cap
11.80M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20261.27M783.00K161.11%
Mar 31, 2025486.00K-578.00K-54.32%
Mar 31, 20241.06M1.29M-
Mar 31, 2023-227.00K-1.34M-
Mar 31, 20221.11M19.40K1.78%
Mar 31, 20211.09M--
Mar 31, 2020---
Mar 31, 2019---
Mar 31, 2018---
Mar 31, 20171.25M--
Mar 31, 2016---
Mar 31, 2015---
Mar 31, 2014---
Mar 31, 2013200.40K-1.14M-85.07%
Mar 31, 20121.34M-728.80K-35.19%
Mar 31, 20112.07M--
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

VTGN News

More News